Daiichi Seeks Review With High Court Of Patent Term Adjustment Challenge
WASHINGTON, D.C. — A pharmaceutical company on Nov. 13 petitioned the U.S. Supreme Court to consider an appellate court’s ruling rejecting its challenge to the way the U.S. Patent and Trademark...To view the full article, register now.
Already a subscriber? Click here to view full article